MUHAMMAD ABSAR; NAWAF ALANAZI; ABDULAZIZ SIYAL; MASOOD SHAMMAS; AMER MAHMOOD; SULMAN BASIT; SARAH ALMUKHAYLID; ZAFAR IQBAL. CLINICAL VALIDATION OF ANKRD36 MUTATIONS AS A NOVEL BIOMARKER FOR MONITORING EARLY PROGRESSION AND TIMELY CLINICAL INTERVENTIONS IN BLAST CRISIS CML. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 29, n. 02, p. 311–320, 2022. DOI: 10.53555/jptcp.v29i02.4161. Disponível em: https://jptcp.com/index.php/jptcp/article/view/4161. Acesso em: 16 jul. 2024.